Twitter | Search | |
Stanford Cancer
Highlighting Stanford Medicine's world-class cancer research, prevention and treatment. The Stanford Cancer Institute is dedicated to transforming cancer care.
1,931
Tweets
436
Following
6,609
Followers
Tweets
Stanford Cancer retweeted
Stanford Medicine Dec 4
A new approach to programming cancer-fighting immune cells called CAR-T cells can prolong their activity and increase their effectiveness against human cancer cells grown in the laboratory and in mice, according to a Stanford Medicine study.
Reply Retweet Like
Stanford Cancer retweeted
Steven Artandi, MD, PhD Dec 4
is almost here! I'll be sharing recommendations for exciting talks by SCI members. First up, Ravi Majeti's talk at Friday's Scientific Workshops: Modeling RUNX1-FPD/Acute Myeloid Leukemia Mutations in Primary Human Hematopoietic Stem Cells.
Reply Retweet Like
Stanford Cancer retweeted
Steven Artandi, MD, PhD Dec 3
SCI member James Brooks discusses the risks and benefits of PSA testing, and clarifies some misconceptions about screening.
Reply Retweet Like
Stanford Cancer retweeted
Steven Artandi, MD, PhD Dec 2
SCI leader Sam Gambhir is leading the way in finding innovative ways to detect cancer early. Join us in raising awareness for the potentially lifesaving benefits of cancer screening. Learn more at
Reply Retweet Like
Stanford Cancer Dec 3
This , consider giving a gift that raises spirits worldwide. Stanford's cancer research and discoveries make a real difference for patients everywhere. Please support our work at . We're deeply grateful for your !
Reply Retweet Like
Stanford Cancer retweeted
AASLD Dec 1
From The Liver Meeting 2019 -- "Popper Lecture Examines Role of Subset of Hepatocytes in Regeneration, Disease" Read it here 👉
Reply Retweet Like
Stanford Cancer retweeted
Stanford Medicine Dec 1
Robots at helped Stanford and scientists screen more than 9,000 pairs of drugs to identify two drugs that synergize against a deadly childhood brain tumor, called diffuse intrinsic pontine glioma.
Reply Retweet Like
Stanford Cancer retweeted
Steven Artandi, MD, PhD Nov 28
This , I am thankful for our amazing clinicians, researchers, staff, students, and patients who inspire me each and every day. It is an honor to be part of our SCI community!
Reply Retweet Like
Stanford Cancer retweeted
Steven Artandi, MD, PhD Nov 27
SCI member Ranjana Advani and colleagues explore the prognostic significance of MYC rearrangement and translocation partner in diffuse large b-cell , and discuss diagnostic and therapeutic implications for certain patients.
Reply Retweet Like
Stanford Cancer retweeted
Steven Artandi, MD, PhD Nov 26
SCI member Youn Kim and colleagues found in a phase II trial that pembrolizumab demonstrated significant antitumor activity, with durable responses and a favorable safety profile, in patients with advanced and .
Reply Retweet Like
Stanford Cancer retweeted
Steven Artandi, MD, PhD Nov 25
SCI members Jim Ford and Michael Snyder used deep bisulfite sequencing to find that DNA methylation may play a broader role in early-onset familial .
Reply Retweet Like
Stanford Cancer retweeted
Steven Artandi, MD, PhD Nov 22
. and researchers identified unique characteristics of VISTA, an immune checkpoint protein that inhibits T cell response against . Their insights could guide future development of drugs that target these proteins.
Reply Retweet Like
Stanford Cancer retweeted
Steven Artandi, MD, PhD Nov 21
Congratulations to Hongjie Dai, Julie Parsonnet and Joseph Wu on being elected to the National Academy of Medicine! Proud to have you as members of the Cancer Institute.
Reply Retweet Like
Stanford Cancer retweeted
Grant Lin Nov 20
Excited to share our work on searching for therapeutic strategies for diffuse midline gliomas, that also uncovered metabolic vulnerabilities in this fatal childhood brain tumor.
Reply Retweet Like
Stanford Cancer retweeted
Steven Artandi, MD, PhD Nov 20
SCI members Crystal Mackall and Robbie Majzner discuss major factors affecting the efficacy of therapy, lessons learned from clinical trials, and future directions for research.
Reply Retweet Like
Stanford Cancer retweeted
Stanford Medicine Nov 21
Screening more than 9,000 pairs of drugs helped Stanford and NIH scientists identify two drugs that synergize against a deadly childhood brain tumor.
Reply Retweet Like
Stanford Cancer retweeted
Stanford Medicine Nov 21
For 40 years, scientists have struggled to develop chemotherapy for , a lethal childhood brain tumor. Now, Stanford's and researchers have identified a two-drug combination that could help researchers develop better treatments.
Reply Retweet Like
Stanford Cancer retweeted
OncLive.com Nov 13
Targeted therapies had yet to demonstrate significant efficacy against lung cancer when chose to specialize in thoracic oncology, and checkpoint inhibitors were still years away from introduction
Reply Retweet Like
Stanford Cancer retweeted
OncLive.com Nov 13
Shaping the Future in Lung Cancer
Reply Retweet Like
Stanford Cancer retweeted
Stanford Epidemiology News Nov 13
Mark your calendars! Stanford EPI and are hosting a talk by Harvard's Timothy Rebbeck on "Cancer Prevention and Early Detection in the Era," Thurs 12/5 3pm in LKSC, LK120
Reply Retweet Like